Funding for this research was provided by:
the second batch of science and technology plan projects of Jinan Municipal Health and Health Commission in 2020 (2020-4-181)
Beijing Bethune Public Welfare Foundation, Translational Medicine Research Fund of Tumor radiotherapy (flzh202111)
Wu Jieping Medical Foundation, Special fund for clinical research (320.6750.2021-01-35)
Article History
Received: 7 May 2023
Accepted: 7 November 2023
First Online: 11 November 2023
Declarations
:
: Ethical approval for this study was provided by the Ethics Committee of the Affiliated Cancer Hospital of Shandong First Medical University (approval number SDTHEC20220011008), Jinan, China on November 14, 2022. This study was conducted following the principles outlined in the Declaration of Helsinki. Because this study was a retrospective study, the Ethics Committee of the Cancer Hospital Affiliated to Shandong First Medical University agreed that informed consent was not required and was waived.
: Not applicable
: The authors declare no competing interests.